{'52WeekChange': -0.4133333,
 'SandP52WeekChange': None,
 'address1': 'Minrav Building',
 'address2': 'Fifth Floor Kiryat Hadassah PO Box 12117',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 2.06,
 'askSize': 1100,
 'averageDailyVolume10Day': 4343775,
 'averageVolume': 648830,
 'averageVolume10days': 4343775,
 'beta': 1.660742,
 'beta3Year': None,
 'bid': 1.94,
 'bidSize': 2200,
 'bookValue': 0.549,
 'category': None,
 'circulatingSupply': None,
 'city': 'Jerusalem',
 'companyOfficers': [],
 'country': 'Israel',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 2.07,
 'dayLow': 1.94,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -2.132,
 'enterpriseToRevenue': 85.565,
 'enterpriseValue': 23787066,
 'exDividendDate': None,
 'exchange': 'NCM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 1.8952286,
 'fiftyTwoWeekHigh': 3.7,
 'fiftyTwoWeekLow': 1.35,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 8854341,
 'forwardEps': -0.53,
 'forwardPE': -3.811321,
 'fromCurrency': None,
 'fullTimeEmployees': 21,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'headSymbol': None,
 'heldPercentInsiders': 0.41222998,
 'heldPercentInstitutions': 0.10553,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/enterabio.com',
 'longBusinessSummary': 'Entera Bio Ltd., a clinical-stage biopharmaceutical '
                        'company, focuses on the development and '
                        'commercialization of orally delivered large molecule '
                        "therapeutics for unmet medical needs. The company's "
                        'lead product includes the EB612, an oral parathyroid '
                        'hormone product candidate that has completed a Phase '
                        'IIa clinical trial for hypoparathyroidism. It is also '
                        'developing EB613 that has completed Phase I clinical '
                        'trials for the treatment of osteoporosis and '
                        'non-union fractures. The company was founded in 2010 '
                        'and is headquartered in Jerusalem, Israel.',
 'longName': 'Entera Bio Ltd.',
 'market': 'us_market',
 'marketCap': 36833084,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_106997294',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -10718000,
 'nextFiscalYearEnd': 1640908800,
 'open': 2.01,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '972 2 532 7151',
 'previousClose': 2.2,
 'priceHint': 4,
 'priceToBook': 3.679417,
 'priceToSalesTrailing12Months': 132.4931,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 2.07,
 'regularMarketDayLow': 1.94,
 'regularMarketOpen': 2.01,
 'regularMarketPreviousClose': 2.2,
 'regularMarketPrice': 2.01,
 'regularMarketVolume': 1388436,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 18234200,
 'sharesPercentSharesOut': 0.0013,
 'sharesShort': 24234,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 1075,
 'shortName': 'Entera Bio Ltd.',
 'shortPercentOfFloat': 0.0015,
 'shortRatio': 0.19,
 'startDate': None,
 'strikePrice': None,
 'symbol': 'ENTX',
 'threeYearAverageReturn': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -0.778,
 'twoHundredDayAverage': 2.3414316,
 'underlyingExchangeSymbol': None,
 'underlyingSymbol': None,
 'uuid': 'dd427383-c806-3358-ad72-316161860c8a',
 'volume': 1388436,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.enterabio.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '9112002'}